...
首页> 外文期刊>Journal of hypertension >Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
【24h】

Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.

机译:长期服用依那普利和氯沙坦对一肾一夹高血压大鼠的肾脏影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To compare the effects of chronic administrations of the angiotensin II antagonist losartan and of the angiotensin I converting enzyme inhibitor enalapril on renal function in sodium-depleted rats with one-kidney, one clip hypertension, and to examine the contribution of endogenous kinins to the effect of enalapril. METHODS: We administered enalapril and losartan (10 and 30 mg/kg per day, respectively) for 6 days to hypertensive rats that had been subjected to dietary sodium-intake restriction for 6 days prior to treatment and continued to be subjected to this restriction during treatment. In an additional group, administration of enalapril was combined with infusion of the bradykinin B2-receptor antagonist Hoe 140 (300 microg/kg per day subcutaneously via an osmotic pump). Renal function of anesthetized rats was assessed by using a clearance technique. RESULTS: Despite there being similar falls in arterial pressure, glomerular filtration rate (867 +/- 40 microl/min per g kidney weight in untreated rats) was decreased to a larger extent in enalapril-treated than it was in losartan-treated rats (284 +/- 29 versus 438 +/- 36 microl/min per g kidney weight, P < 0.01). Although infusion of Hoe 140 had no influence on the effect of enalapril on arterial pressure, the level of glomerular filtration achieved in rats of this group (545 +/- 55 microl/min per g kidney weight) was similar to that found in losartan-treated rats. No effect of either treatment on renal plasma flow was detected; as a consequence, the excessive decrease in filtration fraction observed for rats in the enalapril-treated group was corrected by concomitant administration of Hoe 140. Interestingly, administration of enalapril resulted in a greater loss of sodium than did administration of losartan (723 +/- 147 versus 308 +/- 57 micromol during 6 days), and this effect was abolished by infusion of Hoe 140 (353 +/- 42 micromol during 6 days). CONCLUSION: Administration of enalapril to sodium-depleted rats with one-kidney, one clip hypertension reduces their glomerular filtration rate to a greater extent than does administration of losartan despite these agents having similar effects on systemic blood pressure. Combined administration of enalapril and Hoe 140 has a less marked effect on glomerular filtration rate than does that of enalapril alone. This suggests that kinins play a role in the regulation of efferent arteriolar tone in this rat model.
机译:目的:比较长期服用血管紧张素II拮抗剂洛沙坦和血管紧张素I转化酶抑制剂依那普利对单肾一夹高血压的钠缺乏大鼠肾功能的影响,并研究内源性激肽对肾功能的影响。依那普利的作用。方法:我们对治疗前6天已接受饮食钠摄入限制的高血压大鼠给予依那普利和氯沙坦(分别为每天10和30 mg / kg)治疗6天,并在治疗期间继续受到该限制治疗。在另一组中,依那普利的给药与缓激肽B2受体拮抗剂Hoe 140的输注(通过渗透泵每天皮下注射300微克/千克)结合使用。通过清除技术评估麻醉大鼠的肾功能。结果:尽管动脉压下降相似,但依那普利治疗组的肾小球滤过率降低(在每克肾脏重867 +/- 40微升/分钟,每克肾重)比氯沙坦治疗组降低得更大(每克肾脏重284 +/- 29微升/分钟438 +/- 36微升/分钟,P <0.01)。尽管Hoe 140的输注对依那普利对动脉压的影响没有影响,但该组大鼠的肾小球滤过水平(每克肾重545 +/- 55微升/分钟)与氯沙坦-相似。治疗的大鼠。未检测到任何一种治疗对肾血浆流量的影响;因此,通过同时服用Hoe 140可以纠正在依那普利治疗组中观察到的大鼠滤过分数过度降低的现象。有趣的是,依那普利的给药导致钠的损失比氯沙坦的给药更大(723 +/- 147 vs. 308 +/- 57 micromol在6天内),并且通过注入Hoe 140(在6天内353 +/- 42 micromol)消除了这种影响。结论:依那普利对单肾一肾夹闭性高血压钠缺乏大鼠的肾小球滤过率降低的程度比氯沙坦大,尽管这些药物对全身血压的作用相似。与单独使用依那普利相比,依那普利和Hoe 140的联合给药对肾小球滤过率的影响较小。这表明激肽在该大鼠模型的传出小动脉张力的调节中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号